Navigation Links
Metabolex Appoints Raymond Urbanski M.D., Ph.D. to Position of Chief Medical Officer
Date:10/20/2011

HAYWARD, Calif., Oct. 20, 2011 /PRNewswire/ -- Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced today that Dr. Raymond Urbanski has joined the company as Chief Medical Officer.  Dr. Urbanski brings extensive clinical development experience to Metabolex, including expertise in all phases of clinical trial design and execution.

Dr. Urbanski was the Vice President and Medical Head of the Established Products Business Unit at Pfizer since 2008 which he built into a global business. From 2004-2008, he held various positions in the Pfizer Global Pharmaceutics Group.  He was the Vice President for Research and Development at Suntory Pharmaceutical, Inc. from 2001-2004 and held various positions at Aventis and AstraZeneca between 1998 and 2001. He received his Ph.D. in pharmacology and his M.D. from the University of Medicine and Dentistry of New Jersey.

"Ray is a great addition to our management team," said President and Chief Executive Officer Harold Van Wart, Ph.D. "Ray's leadership roles in well respected pharmaceutical companies, his experience in clinical development and his commercial insights will be critical for us as we advance our lead gout drug candidate arhalofenate into Phase 3 studies and ultimate commercialization. He will also be instrumental in helping the company chart the best course for its other two clinical assets – MBX-2982 and MBX-8025."

Metabolex has initiated three 28-day Phase 2b studies for arhalofenate in gout patients.  The first study is a randomized double-blind placebo-controlled study that will evaluate the safety and urate-lowering activity of 400 and 600 mg of arhalofenate used as mono-therapy.  Enrollment into this study of 60 patients with hyperuricemia and a diagnosis of gout has been completed.

Metabolex has also initiated Phase 2b studies in which arhalofenat
'/>"/>

SOURCE Metabolex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Metabolex Initiates Phase 2 Trial of Arhalofenate
2. Metabolex Announces Election of Kurt von Emster to Board of Directors
3. Metabolex Announces Positive Results From Phase 1a Clinical Trial of MBX-2982
4. Two Metabolex Projects Recognized in Windhovers Top 10 Lists for Partnering Opportunities
5. Amgen Appoints Anthony (Tony) Hooper Executive Vice President Global Commercial Operations
6. Kessler Foundation Appoints New Director of Human Performance and Engineering Laboratory
7. China Botanic Appoints Zack Zibing Pan as an Independent Director and Chairman of its Audit Committee
8. Immune Design Corp. Appoints Guy F. Cipriani as Chief Business Officer
9. Amgen Appoints Robert A. Bradway to the Companys Board of Directors
10. PrimeraDx Appoints Jeff Liter as VP of Corporate Development
11. Oncobiologics Appoints Scott Canute, Former President of Eli Lilly and Genzyme, to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... According to a new market report published by ... was valued at USD 3,754.6 million in 2012 and is ... a CAGR of 5.9% from 2013 to 2019. , Nearly ... afflicted by bone and joint disorders, and this number is ... and will continue to increase the demand for orthobiologics. Other ...
(Date:8/29/2014)... August 29, 2014 Three Lawrence ... 2014 Hydrogen Production R&D Award for ... splitting water using sunlight. , Shared with collaborators ... the University of Nevada, Las Vegas (UNLV), the ... models of photoelectrochemical solar-hydrogen production and corrosion processes. ...
(Date:8/28/2014)... August 28, 2014 SPIE Fellow Glenn ... and Optical Science and Director of the Center for ... Carolina at Charlotte, and co-founder and Chairman of the ... as the 2015 Vice President of SPIE, the international ... Philip Stahl announced recent election results at the Annual ...
(Date:8/28/2014)... research platform uses a laser to measure ... stress and heating, an approach likely to ... and batteries., This new technique, called nanomechanical ... and the surface stress of microscale structures ... the merits of surface-stress influence on mechanical ...
Breaking Biology Technology:Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 2Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 3Livermore Team Awarded for Hydrogen Production Research 2Glenn Boreman, UNC Professor and Plasmonics Co-Founder, Elected to SPIE Presidential Chain 2New analytical technology reveals 'nanomechanical' surface traits 2New analytical technology reveals 'nanomechanical' surface traits 3
... , INDIANAPOLIS, Dec. 16 ... strong growth of Indiana,s life sciences industry and an active ... Indiana State Teachers Retirement Fund, Indiana University, Purdue University, the ... Suisse today announced the establishment of the INext Fund, a ...
... biotechnology company,s revenues increase 22% for fiscal 2009; on ... TORONTO, Dec. 16 /PRNewswire-FirstCall/ - Microbix Biosystems Inc. (MBX:TSX) ... today reported financial results for fourth quarter and full-year ... Microbix reported revenues of $6.08 million, a 22% increase ...
... , Trial conducted pursuant to Special Protocol ... CITY, Dec. 16 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ... biopharmaceutical company focused on oncology and endocrine therapy, today ... ("Keryx") ( KERX), of a Phase 3 registration clinical ...
Cached Biology Technology:Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5Microbix' Pipeline Set To Reach Milestones In 2010 2Microbix' Pipeline Set To Reach Milestones In 2010 3Microbix' Pipeline Set To Reach Milestones In 2010 4Microbix' Pipeline Set To Reach Milestones In 2010 5Microbix' Pipeline Set To Reach Milestones In 2010 6Microbix' Pipeline Set To Reach Milestones In 2010 7Microbix' Pipeline Set To Reach Milestones In 2010 8AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5
(Date:8/29/2014)... available in German . ... the natural nitrogen cycle on Earth and in biological ... thought to depend on nitrite as their source of ... Daims, a microbiologist at the University of Vienna, has ... an alternative source of energy. The oxidation of hydrogen ...
(Date:8/29/2014)... City, MO. - In a cell,s nucleus, chromosomal ... as histones, an amalgam biologists call chromatin. Until ... a nuclear "sidekick," the mere packing material around ... however, biologists have developed a greater appreciation for ... 2012, investigators from multiple research institutions studying the ...
(Date:8/28/2014)... app called TX Invasives is now available from the ... Texas at Austin for identifying harmful non-native plant, insect ... in the United States cause about $137 billion in ... crops, clog waterways, kill native plants and more. , ... for reporting where invasive species occur, we,re more likely ...
Breaking Biology News(10 mins):Hydrogen powers important nitrogen-transforming bacteria 2Hydrogen powers important nitrogen-transforming bacteria 3'K-to-M' histone mutations: How repressing the repressors may drive tissue-specific cancers 2'K-to-M' histone mutations: How repressing the repressors may drive tissue-specific cancers 3Mobile app makes ID of harmful plants, insects in Texas a snap 2
... Children's Research Hospital have discovered that a protein called ABCB6 ... is key to the ability of red blood cells to ... of cells to extract energy from nutrients. , The ... outer membrane of the cell's energy powerhouse called ...
... has successfully protected mice and ferrets against a highly ... led the study at St. Jude Children's Research Hospital. ... Diego, California. , This finding, coupled with results of ... strains, suggests that such a vaccine would protect humans ...
... Mayo Clinic Cancer Center has opened a new clinical ... to attack recurrent glioblastoma multiforme, a largely untreatable brain ... molecular medicine studies in patients using measles to kill ... treat some of the most lethal cancers," says Eva ...
Cached Biology News:ABCB6 is key to production of heme in hemoglobin 2St. Jude test of bird flu vaccine proves successful 2Mayo Clinic Cancer Center: Harnessing the measles virus to attack cancer 2Mayo Clinic Cancer Center: Harnessing the measles virus to attack cancer 3
Request Info...
Loading Buffer...
Makes gels easy to load and track during electrophoresis. 10X concentrate of Bromophenol Blue, Xylene Cyanol, glycerol solution in TE...
Epi-Grids™ Colony Grid Templates are easy-to-use griding templates that allow rapid organization of colonies from initial screening plates and for preparing precise master plates....
Biology Products: